/People

Lucio Iannone

Investor

Managing Director at JDRF T1D Fund

Boston, Massachusetts, United States

Find your path to Lucio

375 people in our graph can introduce you to Lucio.

Sign up to see every warm intro you have to Lucio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Lucio. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.

Experience

  1. T1D FundSr Managing Directorcurrent2025 — presentБостон, MA
  2. Amana Global PartnersSenior Investment Advisorcurrent2023 — present
  3. COUR PharmaBoard Observercurrent2025 — present
  4. Leaps by BayerHead of Venture Investments2021 — 2025Кембридж, MA
  5. Leaps by BayerSr Director of Venture Investments2017 — 2021Boston, Massachusetts
  6. Soufflé TherapeuticsBoard Member2023 — 2025
  7. Paratus SciencesBoard Member2022 — 2025Cambridge, Massachusetts, United States
  8. CellinoBoard Member2022 — 2025Cambridge, Massachusetts, United States
  9. Mozart Therapeutics, IncBoard Member2021 — 2025Seattle, Washington, United States
  10. Deka Biosciences, IncBoard Member2021 — 2025Germantown, Maryland, United States
  11. eGenesis, Inc.Board Member2019 — 2025Cambridge, Massachusetts
  12. Immunitas TherapeuticsBoard Member2019 — 2025Cambridge, Massachusetts
  13. Capstan TherapeuticsBoard Observer2023 — 2025Boston, Massachusetts, United States
  14. NextPoint Therapeutics, Inc.Board Observer2022 — 2025Cambridge, Massachusetts, United States
  15. Boundless BioBoard Observer2023 — 2025San Diego, California, United States
  16. Axxam S.p.ABoard Member2019 — 2022
  17. MetagenomiBoard Observer2020 — 2022
  18. Pyxis OncologyBoard Member2019 — 2021Cambridge, Massachusetts
  19. Silence Therapeutics plcHead of Business Development2015 — 2017London, England, United Kingdom
  20. Silence Therapeutics plcScientific Officer Translational Medicine2014 — 2015London
  21. Imperial College LondonCardiovascular Scientist2011 — 2014Londra, Regno Unito

Skills & more

Cell Biology23Biotechnology22Cell Culture9Genetics8Pharmaceutical Industry9Biochemistry6Pharmacokinetics5Lifesciences5Pharmacology4Drug development4Ricerca4Scienza4
+12 moreGeneticaIndustria farmaceuticaBiochimicaBiotecnologiaBiologia molecolareScienze naturaliIn vitroR&DABPI code of practiceReal TimeStrategiaBloomberg

Languages Inglese · Italiano · Portoguese · Spanish

From Lucio's professional profile.

Investments

Per curated public sources.

Colleagues at JDRF T1D Fund

Network2

Investors connected to Lucio in public investor directories — a warm-intro map.

Frequently asked questions

Who is Lucio Iannone?
Lucio Iannone is a Senior Managing Director at T1D Fund, where he focuses on early-stage biotech investments. He works with scientists and entrepreneurs developing medical technologies and therapeutic applications.
Where does Lucio Iannone work?
Lucio Iannone is Managing Director at JDRF T1D Fund.
What companies has Lucio Iannone invested in?
Investments tracked here include Caspian Therapeutics, eGenesis, Immunitas Therapeutics, Mozart Therapeutics, Paratus Sciences.
Where did Lucio Iannone go to school?
Lucio Iannone studied at Imperial College London (Doctor of Philosophy (Ph.D.), Medicine); Università degli Studi di Napoli Federico II (Bachelor's degree, Biotechnology).

Same school

Shared employers